mLabs   Precision POC Testing


The mLabs Platform is an immunoassay diagnostic platform based on our patented microfluidic technologies and advanced fluorescence detection. The result is an accurate, rapid, and reliable POCT system. This compact unit helps diagnose of a number of cardiac diseases within minutes, including deep vein thrombosis, pulmonary embolisms, stroke, sepsis, heart attack, congestive heart failure, and angina.


The mLabs platform includes the mLabs ImmunoMeter and mLabs disposable microfluidic cartridges.


Features include:

  • Rapid test: 4-10 minutes for results

  • Applied samples: Whole blood, plasma and serum

  • High precision: Typical CV% at cutoff is less than 10%

  • Multi-channel testing: Up to 10 channels

  • Easy operation: CLIA waiver compliance

  • High sensitivity: pg/ml

  • Ultra wide dynamic range: Up to 9 orders of magnitude


Available mLabs Tests:


mLabs   Immunometer 




U.S. Headquarters


Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States


T:+1 (408) 588-1682
F:+1 (408) 588-1620



European Office


Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble



T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office


Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong



T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.